* Phio Pharmaceuticals filed a Form 3 naming Ronald Todd Plott as a director on July 20, 2026.
Back to newsPhio Pharmaceuticals director Ronald Todd Plott files initial beneficial ownership statementPPHIO•2026-07-30Form 3 filing names new director Phio Pharmaceuticals filed a Form 3 naming Ronald Todd Plott as a director on July 20, 2026. Related NewsKQuaker Houghton Q2 adjusted EPS beats estimates, announces $250 mln buybackKWR•2026-07-30VVivoSim Labs announces 2026 annual shareholder meetingVIVS•2026-07-30RReddit plunges on slowing Q2 revenue and US daily user growthRDDT•2026-07-30SourcesSSPhio Pharmaceuticals director Ronald Todd Plott files initial beneficial ownership statementSec
PHIO•PHIO•PHIO•PHIO•
